CARD9 and lymphoma: Although the size of our RS cohort was moderate, and further studies with more cases will be required, our results suggested that the expression of CARD9 is neither a feature of CLL, de novo DLBCL or cHL, nor does it represent a general event in the transformation of indolent lymphoma to aggressive lymphoma.